- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 174
Modsy draws up $37m series C
The 3D-imaging interior design service took its overall funding to more than $70m in a round that featured Comcast Ventures and Advance Venture Partners.
May 23, 2019Corporates buy into Biofourmis in $35m round
MassMutual Ventures co-led the healthcare data platform developer's series B round, which also featured Aviva Ventures and Jianke.
May 23, 2019Sun Basket orders $30m in fresh funding
Unilever Ventures participated in a series E round that increased the healthy meal delivery service's overall funding to $125m.
May 22, 2019Robin lands on $20m for series B
Allegion's corporate venturing arm has taken part in a $20m round for the office management software provider, whose early backers include Autodesk and Konica Minolta.
May 22, 2019Snapsheet lays claim to $29m
The digital insurance software provider Snapsheet has closed a $29m series E featuring Nationwide, Sedgwick, State Automobile Mutual Insurance Liberty Mutual, Fidelity and USAA.
May 21, 2019Prowler.io pounces on $24m
CIC has returned to supply AI forecasting platform Prowler.io with series B capital and help take the company's overall funding to $39m.
May 21, 2019Prowler.io pounces on $24m
Pearson, Tencent and Mandatum Life helped supply the AI forecasting platform developer with series B capital that took its total funding to $39m.
May 21, 2019Storm attracts more series A funding
M Ventures, Pfizer Ventures and Taiho Ventures all returned to help boost cancer drug developer Storm Therapeutics' series A round to $38.2m.
May 20, 2019Storm's series A continues to resound with investors
Cambridge's cancer drug spinout Storm Therapeutics convinced its existing investors to join new participant Seroba Life Sciences for a second extension that brought its series A total to $38.2m.
May 20, 2019DNA Script reaches series B chapter
Illumina Ventures and M Ventures made follow-on investments in synthetic DNA platform developer DNA Script as part of its $38.5m series B round.
May 20, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


